title: Is a mechanical or a metabolic approach superior in the treatment of coronary disease? Results of the atorvastatin versus revascularization (AVERT) trial.
authors: D P
authors: DP
authors: Mikhaildis
authors: A S
authors: AS
authors: Wierzbicki
authors: T M
authors: TM
authors: Reynolds
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000069059:Atorvastatin; D003327:Coronary Disease / Q000378:metabolism* / Q000628:therapy*; D006538:Heptanoic Acids / Q000627:therapeutic use; D006801:Humans; D009204:Myocardial Revascularization; D011758:Pyrroles / Q000627:therapeutic use
chemical_list: D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin